The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
A system for functional analysis of Ebola virus glycoprotein
Open accessAbstract
Ebola virus causes hemorrhagic fever in humans and nonhuman primates, resulting in mortality rates of up to 90%. Studies of this virus have been hampered by its extraordinary pathogenicity, which requires biosafety level 4 containment. To circumvent this problem, we developed a novel complementation system for functional analysis of Ebola virus glycoproteins. It relies on a recombinant vesicular stomatitis virus (VSV) that contains the green fluorescent protein gene instead of the receptor-binding G protein gene (VSVΔG*). Herein we show that Ebola Reston virus glycoprotein (ResGP) is efficiently incorporated into VSV particles. This recombinant VSV with integrated ResGP (VSVΔG*-ResGP) infected primate cells more efficiently than any of the other mammalian or avian cells examined, in a manner consistent with the host range tropism of Ebola virus, whereas VSVΔG* complemented with VSV G protein (VSVΔG*-G) efficiently infected the majority of the cells tested. We also tested the utility of this system for investigating the cellular receptors for Ebola virus. Chemical modification of cells to alter their surface proteins markedly reduced their susceptibility to VSVΔG*-ResGP but not to VSVΔG*-G. These findings suggest that cell surface glycoproteins with N-linked oligosaccharide chains contribute to the entry of Ebola viruses, presumably acting as a specific receptor and/or cofactor for virus entry. Thus, our VSV system should be useful for investigating the functions of glycoproteins from highly pathogenic viruses or those incapable of being cultured in vitro .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green fluorescent protein as a marker for gene expression
Chalfie, M., Tu, Y., Euskirchen, G., Ward, W. W., & Prasher, D. C. (1994) · Science · doi:10.1126/science.8303295 · Cited by 6,802
Efficient selection for high-expression transfectants with a novel eukaryotic vector
Hitoshi, N., Ken-ichi, Y., & Jun-ichi, M. (1991) · Gene · doi:10.1016/0378-1119(91)90434-d · Cited by 5,134
Fuerst, T. R., Niles, E. G., Studier, F. W., & Moss, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8122 · Cited by 2,089
Herpes Simplex Virus-1 Entry into Cells Mediated by a Novel Member of the TNF/NGF Receptor Family
Montgomery, R. I., Warner, M. S., Lum, B. J., & Spear, P. G. (1996) · Cell · doi:10.1016/s0092-8674(00)81363-x · Cited by 1,100
Recombinant vesicular stomatitis viruses from DNA.
Lawson, N. D., Stillman, E. A., Whitt, M. A., & Rose, J. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4477 · Cited by 615
Self-citationMarsh, M., & Helenius, A. (1989) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60583-7 · Cited by 602
Sanchez, A., Trappier, S. G., Mahy, B. W., Peters, C. J., & Nichol, S. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3602 · Cited by 552
Self-citationThe asialoglycoprotein receptor: a model for endocytic transport receptors
Spiess, M. (1990) · Biochemistry · doi:10.1021/bi00495a001 · Cited by 485
Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones.
Whelan, S. P., Ball, L. A., Barr, J. N., & Wertz, G. T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8388 · Cited by 484
Sanchez, A., Kiley, M. P., Holloway, B. P., & Auperin, D. D. (1993) · Virus Research · doi:10.1016/0168-1702(93)90063-s · Cited by 318
Self-citation
Cited by
Letko, M., Marzi, A., & Munster, V. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0688-y · Cited by 3,109
Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
Carette, J. E., Raaben, M., Wong, A. C., Herbert, A. S., Obernosterer, G., Mulherkar, N., Kuehne, A. I., Kranzusch, P. J., Griffin, A. M., Ruthel, G., et al. (2011) · Nature · doi:10.1038/nature10348 · Cited by 1,303
Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., et al. (2020) · Science · doi:10.1126/science.abd0831 · Cited by 1,253
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Hansen, J., Baum, A., Pascal, K. E., Russo, V., Giordano, S., Wloga, E., Fulton, B. O., Yan, Y., Koon, K., Patel, K., et al. (2020) · Science · doi:10.1126/science.abd0827 · Cited by 1,210
SLAM (CDw150) is a cellular receptor for measles virus
Tatsuo, H., Ono, N., Tanaka, K., & Yanagi, Y. (2000) · Nature · doi:10.1038/35022579 · Cited by 1,054
Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme
White, J. M., Delos, S. E., Brecher, M., & Schornberg, K. (2008) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230802058320 · Cited by 892
Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection
Chandran, K., Sullivan, N. J., Felbor, U., Whelan, S. P., & Cunningham, J. M. (2005) · Science · doi:10.1126/science.1110656 · Cited by 826
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor
Lee, J. E., Fusco, M. L., Hessell, A. J., Oswald, W. B., Burton, D. R., & Saphire, E. O. (2008) · Nature · doi:10.1038/nature07082 · Cited by 736
Jacob, S. T., Crozier, I., Fischer, W. A., Hewlett, A., Kraft, C. S., Vega, M.-A. D. L., Soka, M. J., Wahl, V., Griffiths, A., Bollinger, L., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0147-3 · Cited by 664
Thomson, E. C., Rosen, L. E., Shepherd, J. G., Spreafico, R., da Silva Filipe, A., Wojcechowskyj, J. A., Davis, C., Piccoli, L., Pascall, D. J., Dillen, J., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.037 · Cited by 606
EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus
Negrete, O. A., Levroney, E. L., Aguilar, H. C., Bertolotti-Ciarlet, A., Nazarian, R., Tajyar, S., & Lee, B. (2005) · Nature · doi:10.1038/nature03838 · Cited by 570
Simmons, G., Reeves, J. D., Rennekamp, A. J., Amberg, S. M., Piefer, A. J., & Bates, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306446101 · Cited by 543
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape
Starr, T. N., Czudnochowski, N., Liu, Z., Zatta, F., Park, Y.-J., Addetia, A., Pinto, D., Beltramello, M., Hernandez, P., Greaney, A. J., et al. (2021) · Nature · doi:10.1038/s41586-021-03807-6 · Cited by 515
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
McCallum, M., Bassi, J., De Marco, A., Chen, A., Walls, A. C., Di Iulio, J., Tortorici, M. A., Navarro, M.-J., Silacci-Fregni, C., Saliba, C., et al. (2021) · Science · doi:10.1126/science.abi7994 · Cited by 412
Systematic identification of type I and type II interferon-induced antiviral factors
Liu, S.-Y., Sanchez, D. J., Aliyari, R., Lu, S., & Cheng, G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114981109 · Cited by 445
Harty, R. N., Brown, M. E., Wang, G., Huibregtse, J., & Hayes, F. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250277297 · Cited by 438
Nanbo, A., Imai, M., Watanabe, S., Noda, T., Takahashi, K., Neumann, G., Halfmann, P., & Kawaoka, Y. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001121 · Cited by 437
Self-citationWhitt, M. A. (2010) · Journal of Virological Methods · doi:10.1016/j.jviromet.2010.08.006 · Cited by 426
Self-citationRole of Endosomal Cathepsins in Entry Mediated by the Ebola Virus Glycoprotein
Schornberg, K., Matsuyama, S., Kabsch, K., Delos, S., Bouton, A., & White, J. (2006) · Journal of Virology · doi:10.1128/jvi.80.8.4174-4178.2006 · Cited by 414
Virus–Receptor Interactions: The Key to Cellular Invasion
Maginnis, M. S. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.06.024 · Cited by 413
Al-Bari, M. A. A. (2017) · Pharmacology Research & Perspectives · doi:10.1002/prp2.293 · Cited by 382
Garbutt, M., Liebscher, R., Wahl-Jensen, V., Jones, S., Möller, P., Wagner, R., Volchkov, V., Klenk, H.-D., Feldmann, H., & Ströher, U. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5458-5465.2004 · Cited by 381
Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry
Tscherne, D. M., Jones, C. T., Evans, M. J., Lindenbach, B. D., McKeating, J. A., & Rice, C. M. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1734-1741.2006 · Cited by 380
Kondratowicz, A. S., Lennemann, N. J., Sinn, P. L., Davey, R. A., Hunt, C. L., Moller-Tank, S., Meyerholz, D. K., Rennert, P., Mullins, R. F., Brindley, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019030108 · Cited by 377
RNA interference is an antiviral defence mechanism in Caenorhabditis elegans
Wilkins, C., Dishongh, R., Moore, S. C., Whitt, M. A., Chow, M., & Machaca, K. (2005) · Nature · doi:10.1038/nature03957 · Cited by 354
Self-citationEbola Virus VP40 Drives the Formation of Virus-Like Filamentous Particles Along with GP
Noda, T., Sagara, H., Suzuki, E., Takada, A., Kida, H., & Kawaoka, Y. (2002) · Journal of Virology · doi:10.1128/jvi.76.10.4855-4865.2002 · Cited by 349
Self-citationThe small RING finger protein Z drives arenavirus budding: Implications for antiviral strategies
Perez, M., Craven, R. C., & de la Torre, J. C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2133782100 · Cited by 338
Ebola virus entry requires the host‐programmed recognition of an intracellular receptor
Miller, E. H., Obernosterer, G., Raaben, M., Herbert, A. S., Deffieu, M. S., Krishnan, A., Ndungo, E., Sandesara, R. G., Carette, J. E., Kuehne, A. I., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.53 · Cited by 335
Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses
Martines, R. B., Ng, D. L., Greer, P. W., Rollin, P. E., & Zaki, S. R. (2015) · The Journal of Pathology · doi:10.1002/path.4456 · Cited by 319
The NS1 Gene Contributes to the Virulence of H5N1 Avian Influenza Viruses
Li, Z., Jiang, Y., Jiao, P., Wang, A., Zhao, F., Tian, G., Wang, X., Yu, K., Bu, Z., & Chen, H. (2006) · Journal of Virology · doi:10.1128/jvi.00993-06 · Cited by 315
Volchkov, V. E., Volchkova, V. A., Mühlberger, E., Kolesnikova, L. V., Weik, M., Dolnik, O., & Klenk, H.-D. (2001) · Science · doi:10.1126/science.1057269 · Cited by 303
Tyro3 Family-Mediated Cell Entry of Ebola and Marburg Viruses
Shimojima, M., Takada, A., Ebihara, H., Neumann, G., Fujioka, K., Irimura, T., Jones, S., Feldmann, H., & Kawaoka, Y. (2006) · Journal of Virology · doi:10.1128/jvi.01157-06 · Cited by 292
Self-citationEbola Virus VP40-Induced Particle Formation and Association with the Lipid Bilayer
Jasenosky, L. D., Neumann, G., Lukashevich, I., & Kawaoka, Y. (2001) · Journal of Virology · doi:10.1128/jvi.75.11.5205-5214.2001 · Cited by 286
Self-citationRole of the Phosphatidylserine Receptor TIM-1 in Enveloped-Virus Entry
Moller-Tank, S., Kondratowicz, A. S., Davey, R. A., Rennert, P. D., & Maury, W. (2013) · Journal of Virology · doi:10.1128/jvi.01025-13 · Cited by 285
Chimpanzee Adenovirus Vector Ebola Vaccine
Ledgerwood, J. E., DeZure, A. D., Stanley, D. A., Coates, E. E., Novik, L., Enama, M. E., Berkowitz, N. M., Hu, Z., Joshi, G., Ploquin, A., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1410863 · Cited by 285
Ebolavirus Glycoprotein Structure and Mechanism of Entry
Lee, J. E., & Saphire, E. O. (2009) · Future Virology · doi:10.2217/fvl.09.56 · Cited by 281
Broad sarbecovirus neutralization by a human monoclonal antibody
Tortorici, M. A., Czudnochowski, N., Starr, T. N., Marzi, R., Walls, A. C., Zatta, F., Bowen, J. E., Jaconi, S., Di Iulio, J., Wang, Z., et al. (2021) · Nature · doi:10.1038/s41586-021-03817-4 · Cited by 266
Mitochondrial Membrane Potential Is Required for MAVS-Mediated Antiviral Signaling
Koshiba, T., Yasukawa, K., Yanagi, Y., & Kawabata, S.-I. (2011) · Science Signaling · doi:10.1126/scisignal.2001147 · Cited by 257
Mitofusin 2 Inhibits Mitochondrial Antiviral Signaling
Yasukawa, K., Oshiumi, H., Takeda, M., Ishihara, N., Yanagi, Y., Seya, T., Kawabata, S.-I., & Koshiba, T. (2009) · Science Signaling · doi:10.1126/scisignal.2000287 · Cited by 255
Covalent Modifications of the Ebola Virus Glycoprotein
Jeffers, S. A., Sanders, D. A., & Sanchez, A. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.12463-12472.2002 · Cited by 253
Self-citationSanada, T., Takaesu, G., Mashima, R., Yoshida, R., Kobayashi, T., & Yoshimura, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806923200 · Cited by 66
(2024) · doi:10.1371/journal.ppat.1012704 · Cited by 10
Increased aerosol transmission for B.1.1.7 (alpha variant) over lineage A variant of SARS-CoV-2
Port, J. R., Yinda, C. K., Avanzato, V. A., Schulz, J. E., Holbrook, M. G., van Doremalen, N., Shaia, C., Fischer, R. J., & Munster, V. J. (2021) · doi:10.1101/2021.07.26.453518 · Cited by 9
Molecular insights into nucleocapsid assembly and transport in Marburg and Ebola viruses
Takamatsu, Y., Dolnik, O., Hirabayashi, A., Okamoto, K., Kurashige, T., Shangfan, H., Oda Harumi, C., & Noda, T. (2025) · mBio · doi:10.1128/mbio.01557-25
Metadata
- Authors
- Takada, A., Robison, C., Goto, H., Sanchez, A., Murti, K. G., Whitt, M. A., & Kawaoka, Y.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1997-12-23
- Volume
- 94
- Issue
- 26
- Pages
- 14764-14769
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2080374377
- Cited by
- 575
- References
- 23
- FWCI
- 6.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.